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EDITORIAL
The identification of IgA receptors in human mesangial cells:
In the search for “Eldorado”
IgA nephropathy is the most common primary glomer- IgA1 immune complexes. This present study further
ulonephritis in the world. As many as 30% of patients shows decreased binding and internalization of IgA im-
progress to end-stage renal failure in 10 years. Advanced mune complexes from IgA nephropathy patients and
age, hypertension, proteinuria, and renal impairment at IgA1 immune complexes containing IgG by HepG2, pre-
onset are poor prognostic indicators. Recent data suggest sumably due to the masking of the binding site in IgA1
that IgA nephropathy patients with hematuria and mini- glycans from the asialoglycoprotein receptor (ASPG-R).
mal proteinuria also can develop progressive disease. The failure of an adequate hepatic catabolism may favor
Therefore, elucidation of the pathogenesis of this disease that IgA1-IgG immune complexes increase in blood and
is an urgent task for specific therapy. The hallmark of deposit at the glomerular level in IgA nephropathy pa-
the disease is the presence of IgA in the mesangium, tients.
probably in form of immune complexes. It has been On the other hand, Monteiro et al recently proposed a
assumed that those complexes could interact with resi- different mechanism delivering IgA specific immune com-
dent mesangial cells (and probably with further recruited plexes to the kidney. Based on the findings that FcRI
mononuclear cells) causing proliferation and mesangial (CD89) expression on blood cells was significantly down-
matrix production [1]. Despite that several groups, in- regulated in IgA nephropathy patients, they analyzed hu-
cluding ours, have repeatedly demonstrated that macro- man CD89-transgenic mice [3]. Interestingly, these mice
molecular IgA (in the form of aggregates or immune also showed down-regulation of CD89 on monocytes, he-
complexes) elicited a number of responses in cultured maturia, and proteinuria. These investigators concluded
mesangial cells, the identification of IgA receptors re- that the down-regulation was due to the shedding of CD89
mains elusive. by IgA binding on cellular surface, which resulted in cir-
In the current issue of Kidney International, Novak et culating IgA-soluble CD89 immune complexes that were
al approached this aspect, studying the interactions of deposited in the mesangium. Although several aspects need
human mesangial cells with IgA and IgA-containing im- to be clarified, their hypothesis could be important for
mune complexes [2]. In view of the potential implication the pathogenesis of this disease. In this regard, the poten-
of aberrant glycosylation of IgA1 in the pathogenesis of tial contribution of aberrantly glycosylated IgA1 to the
this disease, they studied some cellular responses (bind- shedding is of great interest.
ing, internalization and catabolic degradation) in human It has been suggested that IgA immune complexes
mesangial cells and hepatocytes (HepG2) stimulated activate mesangial cells, inducing a number of responses,
with circulating immune complexes containing galactose including a strong inflammatory reaction. Consensus ex-
(Gal)-deficient IgA1 and IgG. It is already known that ists in the binding properties of IgA to cultured mesan-
IgA1 molecules from IgA nephropathy patients display gial cells from several species. In cultured mesangial
alterations in O-linked hinge region glycans, usually with cells, the IgA receptors are constitutively expressed and
a reduced content of Gal, therefore exposing the under- able to bind the Fc region of IgA in a class-specific, dose-
lying N-acetylgalactosamine (GalNAc). The group from dependent, and saturable manner. Binding affinity (1 
Alabama previously demonstrated that circulating im- 106 – 7  108 M1) and the number of sites (1  105 –
mune complexes in IgA nephropathy patients were com- 7  106) varied between the studies, but in all cases
posed of aberrantly glycosylated IgA1 and IgG recogniz- polymeric IgA interaction was higher than that of mono-
ing GalNAc as an antigenic determinant (see reference meric IgA [2, 4–6]. Currently, three known IgA receptors
6 in [2]). Since some microorganisms express GalNAc on have been characterized in detail: the polymeric Ig recep-
their surface and are able to elicit an antibody response, tor (pIgR), ASGP-R, and CD89. The pIgR is not a good
they postulated that these naturally occurring IgG and candidate for IgA binding in mesangial cells because of
IgA antibodies may result in circulating Gal-deficient the different characteristics of the mesangial IgA interac-
tion. The ASGP-R is a C-type lectin first described in
hepatocytes that mediates endocytosis of desialylatedKey words: glomerulonephritis, glycosylation, monocytes, hematuria,
proteinuria, Ig nephropathy, Fc receptor, immune complexes. glycoproteins. The ASGP-R is able to bind IgA1 by
interaction with O-linked carbohydrates present in the 2002 by the International Society of Nephrology
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hinge region (see reference 28 in [2]). Other cells, such is able to bind IgA and IgM and its expression is detected
in renal tissues and cultured human mesangial cells [12].as epithelial cells and macrophages, can express this re-
ceptor, which suggests that other organs besides the liver TfR presents remarkably selective affinity for mono-
meric IgA1 and its expression is up-regulated in culturedmay participate in the clearance of serum glycoproteins,
although the potential biological role of extrahepatic mesangial cells and glomeruli from IgA nephropathy
patients [13]. Both receptors exert their function withoutASGP-R has not been fully explored. Several groups
have described the expression of ASGP-R in the kidney FcR common  chain. However,  chain-deficient mice
lacking functional FcR showed significant accumulationand cultured mesangial cells [7, 8], while others could
not identify it [2, 9]. However, interestingly, IgA binding of IgA in glomeruli without appreciable glomerular le-
to mesangial cells increased when aberrantly glycosy- sion (abstract; Kobayahsi N et al, J Am Soc Nephrol
lated. 10:460, 1998). Therefore, further studies will be needed
Controversial issues also exist concerning the CD89 for determining biochemical features of IgA interaction
expression in mesangial cells. The CD89 is a membrane with these receptors.
glycoprotein containing two extracellular domains, a As Novak et al suggest, the existence of a novel IgA
membrane-spanning region and a cytoplasmic tail. CD89 receptor in mesangial cells, totally different in sequence
binds the Fc region of monomeric and pIgA with high from those previously described, is highly possible, al-
affinity and is expressed on the cell surface with or with- though there seems to be no doubt that mesangial cells
out the intracellular signaling molecule, the  chain. do express FcRI and FcRIII for IgG in a similar man-
Some reports have described that the mesangial IgA ner to that of leukocytes. In this regard, the mesangial
receptor was related to the myeloid CD89, and the protein cloning and the generation of specific antibodies
mRNA expression was found in cultured mesangial cells for in vivo studies are important issues to be solved in the
by polymerase chain reaction (PCR) with specific prim- future. Identification of the IgA receptors, in conjunction
ers for different sequences, Northern blot and PCR- with a better knowledge of the abnormal composition
Southern blot [4, 5, 10]. Sequence analysis after subclon- of IgA immune complexes in IgA nephropathy patients,
ing the mesangial receptor revealed similarities with the will help to strengthen our understanding of the patho-
CD89. In addition, its physical association with  chain genesis of this disease and contribute to the discovery
and up-regulation by incubation with cytokines and IgA of specific therapeutic approaches.
were also reported. However, other authors failed to
Carmen Go´mez-Guerrero,find such expression [2, 6, 9].
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